Quest Diagnostics jumps on pre-earnings optimism after April price-target raise
Quest Diagnostics shares jumped after Evercore ISI raised its price target on April 8, 2026, boosting optimism ahead of the company’s Q1 2026 earnings report due April 21, 2026. The move also comes on the dividend payable date of $0.86 per share on April 20, 2026.
1) What’s moving the stock
Quest Diagnostics (DGX) is rallying as investors position ahead of its first-quarter 2026 earnings report scheduled for Tuesday, April 21, 2026, before the market opens. Sentiment has also been supported by a recent Street move: Evercore ISI reported a price-target update on April 8, 2026, helping drive a more constructive setup into the print. (newsroom.questdiagnostics.com)
2) Dividend calendar adds a near-term catalyst
Monday, April 20, 2026 is also the payable date for Quest’s quarterly cash dividend of $0.86 per share. While dividend payments don’t change a company’s fundamentals, dividend-related attention can increase trading activity and keep the name on investor radars alongside the upcoming earnings event. (rttnews.com)
3) Key context investors are weighing
Quest last provided full-year 2026 guidance alongside its Q4 and full-year 2025 results, projecting revenue of $11.70–$11.82 billion and adjusted diluted EPS of $10.50–$10.70, and it increased the quarterly dividend to $0.86. With the Q1 2026 report imminent, today’s move suggests traders are increasingly confident the company can execute against that outlook and potentially reinforce its 2026 trajectory. (newsroom.questdiagnostics.com)